Medtronic enrolls first patients in Hugo surgical robot clinical trial
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot.
Stay updated with breaking news from Surgery Enterprise. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot.
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global healthcare technology leader, has announced three significant global market-entrance and indication...
The Dublin-based company has a lengthy history of inking deals to increase Hugo’s prowess – and just announced a new collaboration.
Medtronic (NYSE:MDT) announced today that it entered into a contract that adds its Touch Surgery Enterprise platform to Vizient's offerings.
/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has entered into a contract with Vizient, a leading...